(Date:5/22/2013)... 2013 Oligomerix, Inc. , a privately ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... B financing, which includes both issuance of new ... approximately $2.8M in new investments in the Company. ... raise. Funding from the Series ...
(Date:5/22/2013)... N.Y. , May 22, 2013 Cleveland BioLabs, Inc. ... present at the Second Annual Marcum LLP Microcap Conference, May ... Neil Lyons , CPA, Chief ... and biodefense programs on May 30 at 1:30 p.m. Eastern ... will be available on the Investors page of the Cleveland ...
(Date:5/22/2013)... Envera announced today that Michael McErlean ... McErlean has an extensive background in cell production and ... career. , Mike Matheny, President and Owner ... Mike join our team”. “Mike’s background is perfectly suited ... and downstream processing equipment”, added Matheny. “Mike’s hands ...
(Date:5/21/2013)... Fla. , May 21, 2013 On ... FCN ), the global business advisory firm ... enterprise value (the "Company"), announced that it has ... that were formerly included within the Corporate Finance/Restructuring ... Consulting segment to form a single integrated practice ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Envera Appoints Michael McErlean Fermentation Manager 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2... 2011 According to results from the most recent ... particularly those in the durable goods sector, suffered from ... rising energy and raw materials costs, and falling business ... fall Monitor participants say their businesses are thriving and ...
... Nov. 21, 2011 OrthoAccel® Technologies, Inc. announced ... Micerium S.p.A. based in Avegno for exclusive distribution ... The AcceleDent™ System is ... the United Kingdom in October 2009. The lightweight appliance, used to ...
... 2011 New Report Added in ResearchMoz Reports ... and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to ... GBI Research . GBI ... - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic ...
Cached Biology Technology:McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 2McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 3McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock 4OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy 2OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy 3ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 2ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 3ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 4Agarase cleaves agarose to neoagaro-oligosaccharides, and is used for,quantitative, gentle recovery of DNA from low melting point agarose....
Request Info...
Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF Protein Family: Coagulation, Serine Protease Regulators...
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
Biology Products:Biology NavigationMedical Navigation